Anhydrous Citric Acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 2 USDMF, 1 CEP/COS, 4 JDMF, 2 NDC API, 6 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

40 Drugs in Development

40 Drugs in Development

FINISHED DOSAGE FORMULATIONS

82 FDF Dossiers, 9 FDA Orange Book, 15 Europe, 49 Canada, 7 South Africa, 2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;IRRIGATION - 6.602GM/100ML;198MG/100ML;3.177GM/100ML, FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

10 Rochem International Inc, 15 SPI Pharma, 2 Seqens, 10 DKSH, 2 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 22 BASF, 1 Bioplus Life Sciences, 2 Clariant, 10 Corel Pharma Chem, 2 DFE Pharma, 2 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 19 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 23 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 33 Thickeners and Stabilizers, 31 Controlled & Modified Release, 28 Direct Compression, 25 Taste Masking, 23 Topical, 22 Parenteral, 21 Film Formers & Plasticizers, 17 Lubricants & Glidants, 17 Granulation, 17 Solubilizers, 14 Chewable & Orodispersible Aids, 14 Co-Processed Excipients, 10 Disintegrants & Superdisintegrants, 9 Empty Capsules, 7 API Stability Enhancers, 6 Emulsifying Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 14 Finished Drug Prices

MARKET PLACE

28 APIs, 1 FDF Dossiers, 13 EXCIPIENTS, 1 Intermediates

PATENTS & EXCLUSIVITIES

10 US Patents

10 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 4 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 209589 / DOSAGE - SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ANHYDROUS CITRIC ACID(UNII: XF417D3PSL) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL)	ANHYDROUS CITRIC ACID	12g in 160
MAGNESIUM OXIDE(UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838)	MAGNESIUM OXIDE	3.5g in 160
SODIUM PICOSULFATE(UNII: LR57574HN8) (DEACETYLBISACODYL - UNII:R09078E41Y)	SODIUM PICOSULFATE	10mg in 160

Inactive Ingredients

Ingredient Name	ASM Aerosol-Service AG
ACESULFAME POTASSIUM(23OV73Q5G9)
CRANBERRY(0MVO31Q3QS)
EDETATE DISODIUM(7FLD91C86K)
MALIC ACID(817L1N4CKP)
SODIUM BENZOATE(OJ245FE5EU)
SODIUM HYDROXIDE(55X04QC32I)
SODIUM METABISULFITE(4VON5FNS3C)
SUCRALOSE(96K6UQ3ZD4)
WATER(059QF0KO0R)

Drug Product Composition: Anhydrous Citric Acid